POLE and colorectal cancer: As the limited amount of FFPE‐derived DNA from precursor lesions was inadequate for clonality analysis and neoantigen prediction, we examined predicted neoantigen clonality in a subset of TCGA colorectal cancers including MMR‐P, MMR‐D and POLE‐mutant subtypes, broadly matched for patient age and tumour stage.